MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

437 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2023-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn about how a woman's health history influences what a normal breast looks like on an MRI. The investigators also want to learn about how the amount of different natural hormones a woman has affects how the breast looks on an MRI. The investigator's hope is that this will help to find women at a high-risk of breast cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study

NCT02301767

Breast Cancer

ACTIVE_NOT_RECRUITING

Low-field MRI for Breast Cancer Screening

NCT05486520

Breast Benign Malignant Neoplasm of Breast Breast Malignant Tumor

UNKNOWN NA

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

NCT03303846

Healthy Subject

ACTIVE_NOT_RECRUITING NA

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

NCT00058058

Breast Cancer Contralateral Breast Cancer

COMPLETED NA

Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI

NCT03709186

Invasive Breast Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Free Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

premenopausal women

Only women already scheduled for a breast MRI will be included in the study, no additional MRIs will be scheduled for study purposes.

questionnaire

Intervention Type BEHAVIORAL

postmenopausal women

Only women already scheduled for a breast MRI will be included in the study, no additional MRIs will be scheduled for study purposes.

questionnaire

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

The study questionnaire is a 15-20 minute survey at or shortly after the time of MRI consisting of 27 questions in 7 domains:background information (e.g., date of birth, country of birth, race/ethnicity), medical history, family history of cancer, reproductive history, use of hormonal medications, alcohol and smoking, contact information/comments.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 21 years or older
* be a cancer-free pre- or postmenopausal woman
* have no prior personal history of any cancer (including DCIS, excluding nonmelanoma skin-cancer)
* able to speak and read English because the questionnaire is only available in English
* able to provide informed consent